The study, known as the NuTra trial, was conducted at a Level I trauma center in Tübingen and published in BMC Geriatrics. Researchers led by Carolina Vogel and Mika F. Rollmann enrolled 218 patients aged 70 or older who had been admitted with fragility fractures — breaks caused by low-energy falls in bones already weakened by age. The participants had a mean age of 81.8 years, and nearly three-quarters were women, reflecting the demographic reality of fragility fractures. Every patient was screened for nutritional risk using two validated instruments: the Nutritional Risk Screening 2002, which weighs weight loss, food intake, and disease severity, and the Mini Nutritional Assessment, which captures broader markers of dietary vulnerability in older adults.

The results of that screening were striking. Nearly half of the patients — 45.9 percent, or 100 of the 218 — screened positive in at least one tool and were classified as being at nutritional risk. These patients were then randomized to receive either a protein-enriched diet targeting 1.5 to 2.0 grams of protein per kilogram of body weight per day, or a standard hospital diet. The remaining 118 patients, who screened negative on both instruments, served as an observational reference group without nutritional risk. This design allowed the team to compare not just the effect of the intervention, but also the baseline consequences of being at nutritional risk in the first place.

Even before any intervention began, the differences between the groups told a clear story. Patients at nutritional risk carried heavier comorbidity burdens, had higher scores on the American Society of Anesthesiologists physical status classification, and were markedly frailer than their well-nourished counterparts. This clustering is not incidental. In geriatric medicine, malnutrition, frailty, and multimorbidity are increasingly understood as overlapping expressions of the same underlying physiological decline — sarcopenia, chronic inflammation, and reduced physiological reserve. The NuTra data reinforce that picture: nutritional risk rarely appears in isolation in this population.

The trial’s primary outcomes were in-hospital medical complications, surgical site infections, and functional mobility at discharge. Medical complications occurred in 45.0 percent of patients overall, a figure that underscores how fragile this population is even under modern trauma care. Yet there were no significant differences between the protein-enriched group and the standard diet group. Serum albumin, a key marker of protein status, decreased during hospitalization in all groups, while C-reactive protein, an indicator of systemic inflammation, increased — and neither trajectory differed between the intervention and control arms. The extra protein, in other words, did not bend the biological curves of the acute hospital stay.

Secondary outcomes told a similar story. Length of hospital stay, in-hospital mortality, and discharge destination showed no measurable benefit from the protein-enriched diet. What did matter was nutritional risk status itself. Patients in the reference group without nutritional risk were more often independently mobile at discharge and more frequently returned home, whereas patients at nutritional risk — whether they received the enriched diet or not — more often required institutional care after leaving the hospital. In multivariable analysis, a higher age-adjusted Charlson Comorbidity Index was independently associated with discharge destination, but the nutritional intervention itself showed no independent effect.

Why did a biologically plausible intervention fail? The authors point to the deeper entanglement of nutritional risk with overall vulnerability. A hospital stay is short — often just days to a couple of weeks — while the physiological deficits that define malnutrition in older adults took years to develop. Reversing them with a few weeks of extra protein at the bedside may simply be asking too much of too brief an intervention. Bone healing, immune competence, and muscle rebuilding all operate on timescales of months, not days. The NuTra trial suggests that the acute in-hospital phase may be the wrong window to expect measurable returns from nutritional therapy alone, even when the therapy is well targeted.

There are also technical considerations worth weighing. The trial was single-center, and the intervention was delivered during the hospital stay only, without structured follow-up supplementation after discharge. The screening tools, while validated, may capture a heterogeneous mix of patients — some with reversible acute deficits, others with entrenched chronic malnutrition. And the primary outcomes, focused on the short term, may not have been sensitive to benefits that could emerge later in rehabilitation. The study was retrospectively registered at ClinicalTrials.gov, and the authors themselves frame the findings as hypothesis-shaping rather than practice-defining.

The clinical implications are nonetheless significant. For geriatric trauma units, the message is not that nutrition does not matter — it is that nutrition alone, delivered in isolation during a brief hospitalization, is unlikely to move the needle on complications, mobility, or discharge destination. The authors argue that nutritional risk should be considered within the broader context of overall vulnerability, and that nutritional care may need to be embedded in comprehensive longitudinal rehabilitation strategies extending well beyond the acute in-hospital phase. That could mean structured supplementation programs that continue through weeks of outpatient rehabilitation, combined with resistance exercise, geriatric assessment, and social support.

For a field that has long hoped a simple dietary fix could rescue the frailest fracture patients, the NuTra trial is a humbling but clarifying result. It redirects attention from the hospital tray to the longer arc of recovery — and toward integrated models of care that treat malnutrition not as an isolated deficiency to be topped up, but as one thread in the larger fabric of aging. The trial’s findings, published as open access research, are likely to spark renewed debate about how, when, and for whom protein supplementation should be deployed in geriatric trauma care.

Subject of Research: Impact of malnutrition and protein-enriched oral nutrition on early recovery after fragility fractures in older adults: the NuTra trial

Article Title: Impact of malnutrition and protein-enriched oral nutrition on early recovery after fragility fractures in older adults: the NuTra trial

Article References: Vogel, C., Heyl, M., Vollmer, L., Schuhmacher, J., Demissie, J., Haas, D., Braun, B. J., Herath, S. C., Histing, T., & Rollmann, M. F. (2026). Impact of malnutrition and protein-enriched oral nutrition on early recovery after fragility fractures in older adults: the NuTra trial. BMC Geriatrics. https://doi.org/10.1186/s12877-026-08247-3

Image Credits: AI Generated

DOI: 10.1186/s12877-026-08247-3

Keywords: Impact, malnutrition, protein-enriched, oral, nutrition, early, recovery, fragility, fractures, older, adults, NuTra